Formycon Ag
4 products tracked · names used in filings: Formycon Ag, Formycon AG
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 18 Dec 2025🇺🇸 FDA approval
FDA approves biosimilar Nufymco (ranibizumab-leyk)
Formycon Ag; BLA761473; Biosimilar; injection · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Nufymco ranibizumab-leyk | Approved | 2025-12-18 |
| 🇪🇺 | Ahzantive aflibercept | Authorised | 2025-01-13 |
| 🇪🇺 | Baiama aflibercept | Authorised | 2025-01-13 |
| 🇪🇺 | Fymskina ustekinumab | Authorised | 2024-09-25 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.